Clinical trials
Phase 2 Hepatitis D trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 |
| Vir Biotechnology, Inc. | 2 |
| Aga Khan University | 1 |
| Antios Therapeutics, Inc | 1 |
| Arrowhead Pharmaceuticals | 1 |
| HepNet Study House, German Liverfoundation | 1 |
| Hepatera Ltd. | 1 |
| National Taiwan University Hospital | 1 |
| Shanghai HEP Pharmaceutical Co., Ltd. | 1 |
| Ziauddin Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis D | 16 |
| Hepatitis D, Chronic | 6 |
| Hepatitis | 4 |
| Fibrosis | 3 |
| Liver Diseases | 3 |
| Hepatitis B, Chronic | 2 |
| Hepatitis, Chronic | 2 |
| Digestive System Diseases | 1 |
| Glomerulonephritis | 1 |
| Hepatitis B | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.